Few Adverse Cardiovascular Events Among Patients With Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?

Arthritis Rheumatol. 2021 Sep;73(9):1571-1573. doi: 10.1002/art.41801. Epub 2021 Aug 9.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / drug therapy
  • Cardiovascular Diseases* / chemically induced
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / epidemiology
  • Humans
  • Hydroxychloroquine / adverse effects

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine